Evaluating Quality of Life After Different Types of Glaucoma Surgery Including Preserflo MicroShunt, Trabeculectomy, and Deep Sclerectomy with Mitomycin C

What this Trial Is About

Researchers are studying the impact of various glaucoma surgeries on patients quality of life, beyond traditional clinical measures like eye pressure and medication use. This observational study focuses on adult patients with different types and stages of glaucoma who are undergoing specific surgical procedures. The goal is to better understand how surgery and postoperative care affect patients daily lives and well-being. The study evaluates three types of glaucoma surgeries combined with mitomycin C Preserflo MicroShunt implantation, trabeculectomy, and non-penetrating deep sclerectomy. Patients will be observed preoperatively and followed for at least six months after surgery. Quality of life will be assessed using the NEI-VFQ-25 questionnaire, which measures vision-related functioning and general health status. Participants will complete the NEI-VFQ-25 before surgery and again six months afterward. Researchers will collect clinical data on eye pressure, visual acuity, treatment burden, and visual field damage at three and six months post-surgery. The study will also monitor the impact of postoperative follow-up care on quality of life. The total involvement includes preoperative assessment and follow-up visits over six months to evaluate both subjective and objective outcomes.

Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options